Cookie policy notice

By continuing to use this site you agree to our cookies policy below:
Since 26 May 2011, the law now states that cookies on websites can ony be used with your specific consent. Cookies allow us to ensure that you enjoy the best browsing experience.

This site is intended for health professionals only

At the heart of general practice since 1960


The EFSA Journal 2008; 825:1-13

Blair et al. American Journal of Cardiology 2000; 86:46-52

De Jong et al. British Journal of Nutrition 2008; 100: 937-941

NHS Choices. Atherosclerosis (Accessed September 2014).

Baigent, C. et al (2010). Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet. Nov 13; 376(9753):1670-81.

Clarke R, Frost C, Collins R, Appelby P, Peto R. (1997). Dietary Lipids and Blood Cholesterol: a quantitative meta-analysis of metabolic ward studies. British Medical Journal; 314: 112-117.

National Institute for Health and Care Excellence (NICE) (2014). Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease. NICE clinical guideline 181, July.

Miettinen T.A., Puska P., Gylling, H. et al (1995). Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population. New England Journal of Medicine. 333:1308-12.

Andersson, A., Karlstrom, B., Mohsen, R. et al (1999). Cholesterol-lowering effects of a stanol ester-containing low-fat margarine used in conjunction with a strict lipid-lowering diet. European Heart Journal Supplements. 1: S80-S90.

Hallikainen, M., Sarkkinen, E., Gylling, H. et al (2000). Comparison of the effects of plant sterol ester and plant stanol ester-enriched margarines in lowering serum cholesterol concentrations in hypercholesterolaemic subjects on a low-fat diet. European Journal of Clinical Nutrition. 54: 715-725.

Blair S.N., Capuzzi D.M., Gottlieb S.O. et al (2000). Incremental reduction of serum total cholesterol and low-density lipoprotein cholesterol with the addition of plant stanol ester-containing spread to statin therapy. American Journal of Cardiology. 86: 46-52.

Bradford, R.H., Shear, C.L., Chremos, A.N. et al (1991). Expanded Clinical Evaluation of Lovastatin (EXCEL) Study results. I. Effi cacy in modifying plasma lipoproteins and adverse event profi le in 8245 patients with moderate hypercholesterolemia. Archives of Internal Medicine. 151(1): 43-49.

Gylling, H. et al (2014). Plant sterols and plant stanols in the management of dyslipidaemia and prevention of cardiovascular disease. Atherosclerosis 232, 346e360.

Talati, R., Sobieraj, D.M., Makanji, S.S., et al (2010). The comparative efficacy of plant sterols and stanols on serum lipids: a systematic review and meta-analysis. J Am Diet Assoc;110:719–26.

Scholle, J.M., Baker, W.L., Talati, R., et al (2009). The effect of adding plant sterols or stanols to statin therapy in hypercholesterolemic patients: systematic review and metaanalysis. J Am Coll Nutr;28:517–24.

Law M. (2000). Plant sterol and stanol margarines and health. BMJ;320:861–4.

Lipid modification: Cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease. (Accessed 31st July 2014)

Benecol website

HEART UK website

HEART UK website

HEART UK website